Media & Investors

Press Releases

Date Title Media
06/07/21 Final Data from Calithera Biosciences’ Phase 2 CANTATA Study in Renal Cell Carcinoma Presented at 2021 ASCO Annual Meeting
05/27/21 Calithera to Present at the Jefferies 2021 Virtual Healthcare Conference
05/17/21 Calithera Biosciences and Antengene Enter Worldwide License Agreement for Development & Commercialization of CB-708
05/06/21 Calithera Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights
04/30/21 Calithera Biosciences to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
04/28/21 Results from Calithera Biosciences’ CANTATA Study to Be Presented at 2021 ASCO Annual Meeting
03/16/21 Calithera Biosciences Reports Fourth Quarter 2020 Financial Results and Recent Highlights
03/12/21 UPDATE – Calithera Biosciences to Report Fourth Quarter 2020 Financial Results on Tuesday, March 16, 2021
03/10/21 Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021
03/02/21 Calithera to Present at the H.C. Wainwright Virtual Global Life Sciences 2021 Conference
02/22/21 Calithera to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
01/11/21 INCB001158 Biliary Tract Cancer Data to be Presented at 2021 Virtual ASCO Gastrointestinal Cancers Symposium
01/05/21 Calithera to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
01/04/21 Calithera Biosciences Reports CANTATA Study of Telaglenastat in Renal Cell Carcinoma Did Not Achieve Primary Endpoint